[HTML] springer.comFull View

[HTML][HTML] Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis

M Belvederi Murri, A Guaglianone, M Bugliani… - Drugs in R&D, 2015 - Springer
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …
被引用次数：187 相关文章

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

MB Murri, M Bugliani, P Calcagno, M Respino… - Drugs in R&D, 2015 - infona.pl
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

MB Murri, M Bugliani, P Calcagno… - Drugs in R & D …, 2015 - search.proquest.com
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …
[PDF] academia.edu

[PDF][PDF] Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

MB Murri, M Bugliani, P Calcagno, M Respino… - academia.edu
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …

[引用][C] Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

MB Murri, M Bugliani, P Calcagno, M Respino… - Drugs in R&D, 2015 - cir.nii.ac.jp
Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review
and Case Report Analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis.

M Belvederi Murri, M Bugliani, P Calcagno… - Drugs in …, 2015 - search.ebscohost.com
Background: Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …

[引用][C] Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

M Belvederi Murri, A Guaglianone… - DRUGS IN …, 2015 - iris.universitaeuropeadiroma.it
Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and
Case Report Analysis IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie …

Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

A Guaglianone, M Bugliani, P Calcagno, M Respino… - Drugs in R&D, 2015 - europepmc.org
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …

Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis

MB Murri, M Bugliani, P Calcagno… - Drugs in …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …
[PDF] researchgate.net

[PDF][PDF] Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

MB Murri, M Bugliani, P Calcagno, M Respino… - researchgate.net
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …